CERo Therapeutics - $CERO - Ep:033

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/3f/aa/2c/3faa2c38-1689-c3e0-7246-364d8d9a093c/mza_8000196554104980122.jpg/600x600bb.jpg

Nano Cap Podcast

Will Tjernlund

48 episodes

3 days ago

On the Nano Cap Podcast, we dive into the unique world of publicly traded companies with a market capitalization under $50 million – the nano caps. These are not just numbers on a stock ticker; they are stories of ambition, struggle, and triumph. Each episode, I'll sit down with the leaders and visionaries behind these companies. We’ll uncover the challenges they face, the innovations they bring, and the strategies that drive them forward in a competitive market.

Investing

Business

RSS

All content for Nano Cap Podcast is the property of Will Tjernlund and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Investing

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/40221642/40221642-1743431773419-19b671c9a3485.jpg

CERo Therapeutics - $CERO - Ep:033 - Nano Cap Podcast

Nano Cap Podcast

27 minutes 29 seconds

7 months ago

CERo Therapeutics - $CERO - Ep:033 - Nano Cap Podcast

In this conversation, Chris Ehrlich, CEO of CERo Therapeutics, shares his extensive experience in the biotech industry, particularly in cancer treatment and immunotherapy. He discusses the challenges and opportunities within the biotech landscape, including the process of going public, valuations, and the unique aspects of developing T-cell therapeutics. Chris emphasizes the importance of innovation in cancer treatment and outlines the future aspirations for CERo Therapeutics as they move towards clinical trials.

CERo Therapeutics Website https://www.cero.bio/

Nano Cap Podcast Website https://www.nanocappod.com/